EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
June 9, 2026
On January 29, 2026, during IMCAS World Congress in Paris, HTL Biotechnology hosted its first scientific session dedicated to the future of regenerative and aesthetic medicine.
Bringing together experts from industry and clinical practice, the session explored how advanced biopolymers are helping shift aesthetic medicine toward a more regenerative approach, focused on skin quality, tissue repair, and long-term biological function.
Hyaluronic Acid: A Cornerstone of Regenerative Medicine
Dr. Abs Settipalli
Dr. Abs Settipalli highlighted the growing role of hyaluronic acid beyond traditional aesthetic applications. His presentation emphasized how premium-quality HA, supported by advanced manufacturing processes and stringent quality standards, can serve as a powerful platform for innovation in regenerative medicine.
Watch Dr. Abs Settipalli’s presentation:
Bioregenerative Polynucleotides: Targeting Cells and the ECM
Dr. Tingsong Lim
Dr. Tingsong Lim explored how polynucleotides are contributing to a new regenerative paradigm in aesthetics. By supporting fibroblast activity, collagen production, and extracellular matrix remodeling, these DNA-based biopolymers offer a scientifically grounded approach to improving tissue quality and promoting long-term regeneration.
Watch Dr. Tingsong Lim’s presentation:
Recombinant Human Collagen III: A Next-Generation Biopolymer
Lixin Dai, PhD
Lixin Dai, PhD, presented the scientific foundations behind recombinant human collagen III (rHColIII). Produced through biotechnology, this human-identical collagen combines high purity, consistency, and structural precision, opening new opportunities for skin quality improvement and regenerative aesthetic applications.
Watch Dr. Lixin Dai’s presentation:
Expert Roundtable: Shaping the Future of Regenerative Aesthetics
Featuring Dr. Abs Settipalli and Dr. Christoph Martschin
Moderated by Anne-Laure Gaudry
The session concluded with an expert discussion on the future of regenerative aesthetics. The speakers shared perspectives on innovation, scientific validation, and the growing importance of biologically inspired solutions in clinical practice, highlighting the value of collaboration between science and medicine.
Watch the roundtable discussion:
We thank all speakers and attendees who contributed to the success of this first scientific session. As regenerative aesthetics continues to evolve, HTL Biotechnology remains committed to advancing innovation through high-quality, pharmaceutical-grade biopolymers and science-driven development.
Watch the full IMCAS 2026 scientific session replay on our YouTube channel. (Full Video Here)
To see our most recent news,
follow us on LinkedIn
Read more
blog posts from us
-
May 15, 2026Ophthalmic Viscosurgical Devices and Hyaluronic Acid in Cataract Surgery
-
March 27, 2026Dry Eye Disease (DED): HA at the Heart of Therapeutic Solutions
-
March 19, 2026Understanding the Role of Salmon Origin in Polynucleotide Quality
Polynucleotides (PN) play an increasingly important role in regenerative medicine and are now assessed against criteria such as biological quality, safety, traceability, and responsible sourcing. In this context, the origin of polynucleotides has become a structuring factor, influencing both the final product profile and the confidence of stakeholders across the medical value chain. Among the various available sources, polynucleotides derived from wild salmon stand out for a set of specific characteristics.